Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow (NASDAQ:COLL) 2026-03-24
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript
Collegium Pharmaceutical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-03-01
Collegium Pharmaceutical kazancı $0,10 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük